Information Provided By:
Fly News Breaks for May 2, 2017
BSX, ELGX
May 2, 2017 | 09:32 EDT
Stephens analyst Chris Cooley reiterates an Overweight rating and $10 price target Endologix's (ELGX) shares, while transitioning his Best Idea within his Medical Device and Hospital Supply coverage universe from Boston Scientific (BSX) to Endologix. While Endologix has clearly suffered several regulatory setbacks, the analyst remains optimistic Nellix's regulatory development can move forward domestically under the revised IFU and as such the shares should increasingly trade more in-line with industry peers.
News For ELGX;BSX From the Last 2 Days
BSX
Mar 26, 2024 | 05:33 EDT
Scivita Medical and Boston Scientific joined hands again to sign an expanded strategic cooperation arrangement. The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool that combines diagnosis and treatment. Under the arrangement, Scivita Medical will expand its relationship with Boston Scientific for strategic co-development and global distribution activities. Such activities may include collaboration on the co-development of future endoscopic devices, and global distribution opportunities for Scivita Medical's single-use endoscope and imaging devices. It is expected that this expanded arrangement will help bring Scivita Medical products to more hospitals and patients throughout China and other global geographies.